tiprankstipranks
Trending News
More News >
Psyence Biomedical Ltd. (PBM)
:PBM
US Market

Psyence Biomedical (PBM) Income Statement

Compare
155 Followers

Psyence Biomedical Income Statement

Last quarter (Q3 2023), Psyence Biomedical's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Psyence Biomedical's net income was C$-24.76M. See Psyence Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -240.00C$ 0.00C$ 0.00
Operating Expenses
C$ 2.75MC$ 1.29MC$ 334.29K
Depreciation and Amortization
C$ 240.00C$ 0.00C$ 0.00
EBITDA
C$ -2.75MC$ -1.29MC$ -334.29K
Operating Income
C$ -2.75MC$ -1.29MC$ -334.29K
Other Income/Expenses
C$ -48.41MC$ 9.31MC$ 8.56M
Pretax Income
C$ -51.16MC$ 8.01MC$ 8.23M
Net Income
C$ -51.16MC$ 8.01MC$ 8.23M
Per Share Metrics
Basic EPS
C$ -7.85C$ -0.64C$ 0.25
Diluted EPS
C$ -7.85C$ -0.64C$ 0.25
Weighted Average Shares Outstanding
6.52M 32.67M 32.67M
Weighted Average Shares Outstanding (Diluted)
6.52M 32.67M 32.67M
Currency in CAD

Psyence Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis